Can You Get GLP-1 Telehealth in Every State? Availability Guide

GLP-1 telehealth is not uniformly available in all 50 states. Telehealth prescribing laws, controlled substance regulations, prescriber licensing requirements, and compounding pharmacy restrictions vary by state — and those variations determine whether a specific platform can serve you where you live.

Why State Matters

Prescriber licensing. Telehealth prescribers must hold an active license in the state where the patient resides. A physician licensed in Texas cannot prescribe to a patient in California without a California license. Most large telehealth platforms maintain prescriber networks across all 50 states, but some smaller or newer platforms have gaps in coverage.

Telehealth prescribing rules. Most states allow GLP-1 prescribing via telehealth (video or audio consultation) without an in-person visit. However, a few states have additional requirements — such as requiring an initial in-person visit before telehealth follow-ups, or requiring prescribers to document specific clinical elements that go beyond standard telehealth intake. These requirements were largely loosened during COVID-19 and many states have made the relaxed rules permanent, but not all.

Nurse Practitioner prescribing authority. Approximately 26 states grant NPs full practice authority (independent prescribing). In the remaining states, NPs must operate under a physician collaborative agreement. This affects which platforms can serve which states if their prescriber network is NP-heavy — they may not have the physician oversight infrastructure in every restricted state.

Compounding pharmacy shipping. 503A compounding pharmacies must be licensed in the state where the patient resides. If your telehealth platform's partner pharmacy isn't licensed in your state, they can't ship medication to you — even if the prescriber is licensed there. 503B outsourcing facilities have fewer state-by-state restrictions because they're FDA-registered, but the current regulatory environment is tightening 503B operations for GLP-1 products.

Which Platforms Cover All 50 States?

Most established GLP-1 telehealth platforms operate in 48–50 states. The states most likely to have coverage gaps are those with the most restrictive telehealth regulations or where certain prescriber types face practice limitations. Common gap states for smaller platforms include Louisiana, Arkansas, and Indiana — though this changes as platforms expand their prescriber networks.

When you start the intake process on any platform, you'll enter your state of residence. The platform will tell you immediately if they can serve you there. If they can't, you'll need to try a different platform rather than attempting workarounds (like entering a different state — which would result in a prescriber-patient relationship that's invalid under state law).

What If You Move or Travel?

Moving to a new state: Notify your telehealth platform. Your prescriber may need to be changed to someone licensed in your new state. The prescription itself remains valid, but the ongoing prescriber-patient relationship must comply with the new state's telehealth laws. Most platforms handle this seamlessly if you update your address in their system.

Traveling temporarily: If you travel for 1–2 weeks, your existing prescription and medication supply cover you. For longer trips (1+ months), complications arise if you need a refill shipped to a different state than your registered address. Some platforms can ship to an alternate address within the US; others require the shipping address to match your registration state. Check your platform's policy before an extended trip.

Living abroad: GLP-1 telehealth platforms are US-only operations. They cannot prescribe or ship to international addresses. US-licensed compounding pharmacies cannot legally ship compounded medications internationally. If you live abroad, you'll need to access GLP-1 medications through your local healthcare system.

Platforms with Broad State Coverage